Ex-Pfizer CEO Kindler joins up with VC firm

In an answer to one of Big Pharma's where-are-they-now questions, the venture capital firm Lux Capital announced that ex-Pfizer CEO Jeff Kindler joined its healthcare team. Kindler left Pfizer's ($PFE) executive suite in December 2010, and has been serving on the healthcare and pharma boards of other companies ever since. Now, he'll look for VC deals and work with Lux's portfolio companies. Report | More